ITOS
Price
$10.17
Change
-$0.01 (-0.10%)
Updated
Jun 6 closing price
Capitalization
389.24M
59 days until earnings call
PPTDF
Price
$13.53
Change
+$0.43 (+3.28%)
Updated
Apr 24 closing price
Capitalization
1.52B
Interact to see
Advertisement

ITOS vs PPTDF

Header iconITOS vs PPTDF Comparison
Open Charts ITOS vs PPTDFBanner chart's image
iTeos Therapeutics
Price$10.17
Change-$0.01 (-0.10%)
Volume$1.06M
Capitalization389.24M
Peptidream
Price$13.53
Change+$0.43 (+3.28%)
Volume$678
Capitalization1.52B
ITOS vs PPTDF Comparison Chart
Loading...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITOS vs. PPTDF commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a Buy and PPTDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ITOS: $10.06 vs. PPTDF: $13.53)
Brand notoriety: ITOS and PPTDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 1025% vs. PPTDF: 82%
Market capitalization -- ITOS: $389.24M vs. PPTDF: $1.52B
ITOS [@Biotechnology] is valued at $389.24M. PPTDF’s [@Biotechnology] market capitalization is $1.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whilePPTDF’s FA Score has 0 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • PPTDF’s FA Score: 0 green, 5 red.
According to our system of comparison, ITOS is a better buy in the long-term than PPTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 6 TA indicator(s) are bullish.

  • ITOS’s TA Score: 6 bullish, 4 bearish.

Price Growth

ITOS (@Biotechnology) experienced а +22.38% price change this week, while PPTDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ITOS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PPTDF($1.52B) has a higher market cap than ITOS($389M). ITOS YTD gains are higher at: 30.990 vs. PPTDF (-24.202).
ITOSPPTDFITOS / PPTDF
Capitalization389M1.52B26%
EBITDA-153.09MN/A-
Gain YTD30.990-24.202-128%
P/E RatioN/A16.91-
Revenue35MN/A-
Total Cash495MN/A-
Total Debt5.1MN/A-
FUNDAMENTALS RATINGS
PPTDF: Fundamental Ratings
PPTDF
OUTLOOK RATING
1..100
47
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOS
RSI
ODDS (%)
Bearish Trend 13 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
79%
Momentum
ODDS (%)
Bullish Trend 13 days ago
80%
MACD
ODDS (%)
Bullish Trend 13 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
74%
Advances
ODDS (%)
Bullish Trend 28 days ago
72%
Declines
ODDS (%)
Bearish Trend 14 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
90%
Aroon
ODDS (%)
Bullish Trend 13 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
+17.94%
BMRN - ITOS
49%
Loosely correlated
-0.03%
IMNM - ITOS
47%
Loosely correlated
+0.35%
IBO - ITOS
46%
Loosely correlated
-6.44%
RCUS - ITOS
45%
Loosely correlated
+1.11%
BDTX - ITOS
44%
Loosely correlated
-2.93%
More

PPTDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PPTDF has been loosely correlated with ITOS. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PPTDF jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPTDF
1D Price
Change %
PPTDF100%
N/A
ITOS - PPTDF
33%
Loosely correlated
+17.94%
NVAX - PPTDF
32%
Poorly correlated
-6.23%
HOTH - PPTDF
28%
Poorly correlated
-1.43%
ADMA - PPTDF
27%
Poorly correlated
-1.91%
VTYX - PPTDF
27%
Poorly correlated
+0.57%
More